US equities |
SPCX $168.38 ▲+5.93% NVDA $237.24 ▲+1.41% MU $1,066.92 ▼-0.74% TSLA $379.63 ▲+2.44% MSFT $526.24 ▲+1.68% SNDK $1,716.22 ▼-0.22% INTC $117.14 ▼-1.83% META $743.64 ▲+2.14%
FinancialContent

Latest News about KGK Science

Recent news which mentions KGK Science

KGK Sciences And Halucenex Sign Contract For Phase II Clinical Trial On Psilocybin For PTSD
Tickers COPHF KONEF
Tags Psychedelics Najla Guthrie COPHF
From Benzinga
Wellbeing Digital Introduces Women In Psychedelics, A Network For Female Minds In Psychedelics
Tickers KONEF
Tags KGK Science Markets Women In Psychedelics network
From Benzinga